Clinical Trial Update: Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing acarbose versus glibenclamide in Type 2 diabetes mellitus evaluates effects on MAGE (mean amplitude of glycemic excursions) a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Glibenclamide (glibenclamide)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED